- Less than one in five HIV+ women with hazardous drinking reported recent use of any alcohol treatment.
- Half of HIV+ women receiving any alcohol treatment reported receiving multiple treatment services among which Alcoholic Anonymous (AA) was the most common.
- A mixture of factors (income levels, social support, drinking levels, and drug use) was important in explaining utilization of alcohol treatment among HIV+ women with hazardous drinking.
Among 474 HIV+ women reporting recent hazardous drinking, less than one in five (19%) reported recent utilization of any alcohol treatment. Alcoholics Anonymous (AA) was the most commonly reported (12.9%), followed by inpatient detoxification (9.9%) and outpatient alcohol treatment program (7.0%). Half (51%) receiving any alcohol treatment reported utilization of multiple treatments.
Multivariable analyses found alcohol treatment was more often utilized by those who had social support, fewer economic resources (income ≤$12,000 vs. >$12,000), higher levels of drinking (16-35 drinks/week vs. 12-15 drinks/week; 36+ drinks/week vs. 12-15 drinks/week), and those who reported any illicit drug use (OR=2.77, 95% CI=1.44 to 5.34). More efforts are needed to enhance the utilization of alcohol treatment.
Our findings highlight the unique profile of those who utilized alcohol treatment. Such information is vital to improve treatment delivery to address unmet need in this particular population.
Purchase full article at: http://goo.gl/IoaAIx
By: Hu X1, Harman J2, Winterstein AG3, Zhong Y4, Wheeler AL5, Taylor TN6, Plankey M7, Rubtsova A8, Cropsey K9, Cohen MH10, Adimora AA11, Milam J12,Adedimeji A13, Cook RL14.
- 1Department of Epidemiology, College of Public Health and Health Professions, College of Medicine, University of Florida, Gainesville, FL, USA. Electronic address: email@example.com.
- 2Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee, FL, USA.
- 3Department of Epidemiology, College of Public Health and Health Professions, College of Medicine, University of Florida, Gainesville, FL, USA; Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, USA.
- 4The Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.
- 5Department of Medicine, University of California, San Francisco and Department of Veterans Affairs Medical Center, San Francisco, CA, USA.
- 6College of Medicine, State University of New York Downstate Medical Center, Brooklyn, NY, USA.
- 7Georgetown University Medical Center, Department of Medicine, Division of Infectious Diseases, Washington, DC, USA.
- 8Department of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
- 9Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, AL, USA.
- 10Department of Medicine, Stroger Hospital of Cook County Health and Hospital System and Rush University, Chicago, IL, USA.
- 11Division of Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- 12Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
- 13Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
- 14Department of Epidemiology, College of Public Health and Health Professions, College of Medicine, University of Florida, Gainesville, FL, USA.
- J Subst Abuse Treat. 2016 May;64:55-61. doi: 10.1016/j.jsat.2016.01.011. Epub 2016 Feb 15.
More at: https://twitter.com/hiv insight